Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multip... Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharpe & Dohme, and Recepta Biopharma to achieve over a dozen antibody programs. Some of its products include Prophage, AutoSynVax, QS-21 Stimulon, and others. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.43 | -17.2 | 2.5 | 2.59 | 1.93 | 355650 | 2.36356698 | CS |
| 4 | -1.18 | -36.3076923077 | 3.25 | 3.68 | 1.93 | 332195 | 2.92653961 | CS |
| 12 | -0.76 | -26.8551236749 | 2.83 | 4.15 | 1.93 | 412036 | 3.1834788 | CS |
| 26 | -3.38 | -62.0183486239 | 5.45 | 6.53 | 1.93 | 454577 | 3.67225756 | CS |
| 52 | -11.23 | -84.4360902256 | 13.3 | 19.688 | 1.93 | 1381931 | 9.29499739 | CS |
| 156 | -57.13 | -96.5033783784 | 59.2 | 67.4 | 1.93 | 4436685 | 28.95998086 | CS |
| 260 | -53.33 | -96.2635379061 | 55.4 | 135.8 | 1.93 | 4065813 | 46.40775842 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
